nodes	percent_of_prediction	percent_of_DWPC	metapath
Molindone—HTR7—coronary artery disease	0.39	0.665	CbGaD
Molindone—HTR2A—coronary artery disease	0.196	0.335	CbGaD
Molindone—HTR1A—Penbutolol—coronary artery disease	0.0658	1	CbGbCtD
Molindone—HTR7—pulmonary artery—coronary artery disease	0.00682	0.0955	CbGeAlD
Molindone—HTR7—sympathetic nervous system—coronary artery disease	0.00664	0.0928	CbGeAlD
Molindone—HTR2A—arteriole—coronary artery disease	0.00649	0.0909	CbGeAlD
Molindone—HTR7—vagus nerve—coronary artery disease	0.00643	0.0899	CbGeAlD
Molindone—HTR7—vein—coronary artery disease	0.00621	0.0869	CbGeAlD
Molindone—HTR7—autonomic nervous system—coronary artery disease	0.00446	0.0624	CbGeAlD
Molindone—HTR2A—pulmonary artery—coronary artery disease	0.00426	0.0595	CbGeAlD
Molindone—HTR2A—sympathetic nervous system—coronary artery disease	0.00414	0.0579	CbGeAlD
Molindone—HTR2A—vagus nerve—coronary artery disease	0.00401	0.0561	CbGeAlD
Molindone—HTR2A—vein—coronary artery disease	0.00387	0.0542	CbGeAlD
Molindone—HTR2A—autonomic nervous system—coronary artery disease	0.00278	0.0389	CbGeAlD
Molindone—HTR7—artery—coronary artery disease	0.00253	0.0354	CbGeAlD
Molindone—HTR7—endothelium—coronary artery disease	0.00214	0.0299	CbGeAlD
Molindone—HTR2A—artery—coronary artery disease	0.00158	0.0221	CbGeAlD
Molindone—HTR2A—endothelium—coronary artery disease	0.00133	0.0186	CbGeAlD
Molindone—CHRM1—cardiovascular system—coronary artery disease	0.00103	0.0144	CbGeAlD
Molindone—HTR7—heart—coronary artery disease	0.000932	0.013	CbGeAlD
Molindone—HTR1A—cardiovascular system—coronary artery disease	0.00092	0.0129	CbGeAlD
Molindone—HTR7—cardiovascular system—coronary artery disease	0.000879	0.0123	CbGeAlD
Molindone—HTR7—blood—coronary artery disease	0.000695	0.00973	CbGeAlD
Molindone—ADRA2A—heart—coronary artery disease	0.000683	0.00956	CbGeAlD
Molindone—ADRA2A—cardiac atrium—coronary artery disease	0.000584	0.00818	CbGeAlD
Molindone—HTR2A—heart—coronary artery disease	0.000581	0.00813	CbGeAlD
Molindone—HTR2A—cardiovascular system—coronary artery disease	0.000548	0.00767	CbGeAlD
Molindone—Agitation—Acetylsalicylic acid—coronary artery disease	0.00053	0.00376	CcSEcCtD
Molindone—Drowsiness—Trandolapril—coronary artery disease	0.000529	0.00375	CcSEcCtD
Molindone—Leukopenia—Acetylsalicylic acid—coronary artery disease	0.000516	0.00366	CcSEcCtD
Molindone—Weight decreased—Captopril—coronary artery disease	0.000512	0.00363	CcSEcCtD
Molindone—ADRA2A—blood—coronary artery disease	0.00051	0.00713	CbGeAlD
Molindone—Disturbance in sexual arousal—Ramipril—coronary artery disease	0.000508	0.0036	CcSEcCtD
Molindone—Hypotension—Ticagrelor—coronary artery disease	0.000503	0.00357	CcSEcCtD
Molindone—Disturbance in sexual arousal—Timolol—coronary artery disease	0.000496	0.00352	CcSEcCtD
Molindone—Muscle spasms—Fenofibrate—coronary artery disease	0.000495	0.00351	CcSEcCtD
Molindone—Rash—Pitavastatin—coronary artery disease	0.00049	0.00348	CcSEcCtD
Molindone—Drowsiness—Perindopril—coronary artery disease	0.00049	0.00348	CcSEcCtD
Molindone—Dermatitis—Pitavastatin—coronary artery disease	0.00049	0.00348	CcSEcCtD
Molindone—Somnolence—Gemfibrozil—coronary artery disease	0.00049	0.00347	CcSEcCtD
Molindone—Muscle spasms—Clopidogrel—coronary artery disease	0.000487	0.00345	CcSEcCtD
Molindone—Muscle spasms—Lovastatin—coronary artery disease	0.000484	0.00343	CcSEcCtD
Molindone—Dyspnoea—Ticagrelor—coronary artery disease	0.00048	0.0034	CcSEcCtD
Molindone—Drowsiness—Furosemide—coronary artery disease	0.000477	0.00338	CcSEcCtD
Molindone—Muscle spasms—Ezetimibe—coronary artery disease	0.000474	0.00337	CcSEcCtD
Molindone—Vision blurred—Lovastatin—coronary artery disease	0.000474	0.00336	CcSEcCtD
Molindone—Tremor—Lovastatin—coronary artery disease	0.000471	0.00334	CcSEcCtD
Molindone—Constipation—Gemfibrozil—coronary artery disease	0.000471	0.00334	CcSEcCtD
Molindone—Weight increased—Losartan—coronary artery disease	0.000469	0.00333	CcSEcCtD
Molindone—Muscle spasms—Eplerenone—coronary artery disease	0.000464	0.00329	CcSEcCtD
Molindone—Nausea—Pitavastatin—coronary artery disease	0.000462	0.00328	CcSEcCtD
Molindone—Leukopenia—Fenofibrate—coronary artery disease	0.000461	0.00327	CcSEcCtD
Molindone—Disturbance in sexual arousal—Lisinopril—coronary artery disease	0.00046	0.00327	CcSEcCtD
Molindone—Constipation—Ticagrelor—coronary artery disease	0.00046	0.00326	CcSEcCtD
Molindone—Tachycardia—Acetylsalicylic acid—coronary artery disease	0.000459	0.00326	CcSEcCtD
Molindone—Leukopenia—Clopidogrel—coronary artery disease	0.000453	0.00322	CcSEcCtD
Molindone—Muscle spasms—Simvastatin—coronary artery disease	0.000452	0.00321	CcSEcCtD
Molindone—Leukopenia—Lovastatin—coronary artery disease	0.00045	0.00319	CcSEcCtD
Molindone—Vision blurred—Simvastatin—coronary artery disease	0.000443	0.00315	CcSEcCtD
Molindone—Dysphagia—Ramipril—coronary artery disease	0.000442	0.00314	CcSEcCtD
Molindone—Tremor—Simvastatin—coronary artery disease	0.000441	0.00313	CcSEcCtD
Molindone—HTR2A—blood—coronary artery disease	0.000434	0.00607	CbGeAlD
Molindone—Dry mouth—Fenofibrate—coronary artery disease	0.000429	0.00304	CcSEcCtD
Molindone—Muscle spasms—Valsartan—coronary artery disease	0.000427	0.00303	CcSEcCtD
Molindone—Muscle spasms—Olmesartan—coronary artery disease	0.000425	0.00302	CcSEcCtD
Molindone—Leukopenia—Simvastatin—coronary artery disease	0.000421	0.00299	CcSEcCtD
Molindone—Dyspnoea—Acetylsalicylic acid—coronary artery disease	0.00042	0.00298	CcSEcCtD
Molindone—Dry mouth—Lovastatin—coronary artery disease	0.000419	0.00297	CcSEcCtD
Molindone—Vision blurred—Valsartan—coronary artery disease	0.000419	0.00297	CcSEcCtD
Molindone—Somnolence—Acetylsalicylic acid—coronary artery disease	0.000418	0.00297	CcSEcCtD
Molindone—Vision blurred—Olmesartan—coronary artery disease	0.000417	0.00296	CcSEcCtD
Molindone—Muscle spasms—Niacin—coronary artery disease	0.000415	0.00295	CcSEcCtD
Molindone—Constipation—Rosuvastatin—coronary artery disease	0.000414	0.00294	CcSEcCtD
Molindone—Dry mouth—Ezetimibe—coronary artery disease	0.000411	0.00291	CcSEcCtD
Molindone—Tachycardia—Fenofibrate—coronary artery disease	0.00041	0.00291	CcSEcCtD
Molindone—Muscle spasms—Pravastatin—coronary artery disease	0.000409	0.0029	CcSEcCtD
Molindone—Vision blurred—Niacin—coronary artery disease	0.000407	0.00289	CcSEcCtD
Molindone—Agitation—Olmesartan—coronary artery disease	0.000406	0.00288	CcSEcCtD
Molindone—Weight increased—Ramipril—coronary artery disease	0.000403	0.00286	CcSEcCtD
Molindone—Vision blurred—Pravastatin—coronary artery disease	0.000401	0.00284	CcSEcCtD
Molindone—Tremor—Pravastatin—coronary artery disease	0.000399	0.00283	CcSEcCtD
Molindone—Muscle spasms—Trandolapril—coronary artery disease	0.000397	0.00282	CcSEcCtD
Molindone—Leukopenia—Olmesartan—coronary artery disease	0.000396	0.00281	CcSEcCtD
Molindone—Muscle spasms—Enalapril—coronary artery disease	0.000396	0.00281	CcSEcCtD
Molindone—Hypotension—Fenofibrate—coronary artery disease	0.000393	0.00279	CcSEcCtD
Molindone—Weight decreased—Timolol—coronary artery disease	0.000391	0.00277	CcSEcCtD
Molindone—Muscle spasms—Telmisartan—coronary artery disease	0.00039	0.00277	CcSEcCtD
Molindone—Vision blurred—Enalapril—coronary artery disease	0.000388	0.00275	CcSEcCtD
Molindone—Leukopenia—Niacin—coronary artery disease	0.000387	0.00274	CcSEcCtD
Molindone—Hypotension—Clopidogrel—coronary artery disease	0.000386	0.00274	CcSEcCtD
Molindone—Tremor—Enalapril—coronary artery disease	0.000386	0.00273	CcSEcCtD
Molindone—Nausea—Penbutolol—coronary artery disease	0.000384	0.00272	CcSEcCtD
Molindone—Leukopenia—Pravastatin—coronary artery disease	0.000381	0.0027	CcSEcCtD
Molindone—Agitation—Trandolapril—coronary artery disease	0.00038	0.00269	CcSEcCtD
Molindone—Agitation—Enalapril—coronary artery disease	0.000378	0.00268	CcSEcCtD
Molindone—Dyspnoea—Fenofibrate—coronary artery disease	0.000375	0.00266	CcSEcCtD
Molindone—Somnolence—Fenofibrate—coronary artery disease	0.000374	0.00265	CcSEcCtD
Molindone—Vision blurred—Captopril—coronary artery disease	0.000372	0.00264	CcSEcCtD
Molindone—Dry mouth—Valsartan—coronary artery disease	0.00037	0.00262	CcSEcCtD
Molindone—Leukopenia—Trandolapril—coronary artery disease	0.00037	0.00262	CcSEcCtD
Molindone—Dyspnoea—Clopidogrel—coronary artery disease	0.000368	0.00261	CcSEcCtD
Molindone—Muscle spasms—Perindopril—coronary artery disease	0.000368	0.00261	CcSEcCtD
Molindone—Leukopenia—Enalapril—coronary artery disease	0.000368	0.00261	CcSEcCtD
Molindone—Hypotension—Eplerenone—coronary artery disease	0.000368	0.00261	CcSEcCtD
Molindone—Dyspnoea—Lovastatin—coronary artery disease	0.000366	0.0026	CcSEcCtD
Molindone—Weight increased—Lisinopril—coronary artery disease	0.000365	0.00259	CcSEcCtD
Molindone—Weight decreased—Lisinopril—coronary artery disease	0.000363	0.00257	CcSEcCtD
Molindone—Dry mouth—Niacin—coronary artery disease	0.00036	0.00255	CcSEcCtD
Molindone—Constipation—Fenofibrate—coronary artery disease	0.00036	0.00255	CcSEcCtD
Molindone—Dyspnoea—Ezetimibe—coronary artery disease	0.000359	0.00255	CcSEcCtD
Molindone—Tremor—Perindopril—coronary artery disease	0.000359	0.00255	CcSEcCtD
Molindone—Muscle spasms—Furosemide—coronary artery disease	0.000358	0.00254	CcSEcCtD
Molindone—Constipation—Clopidogrel—coronary artery disease	0.000353	0.00251	CcSEcCtD
Molindone—Tachycardia—Olmesartan—coronary artery disease	0.000352	0.0025	CcSEcCtD
Molindone—Agitation—Perindopril—coronary artery disease	0.000352	0.0025	CcSEcCtD
Molindone—Dyspnoea—Eplerenone—coronary artery disease	0.000351	0.00249	CcSEcCtD
Molindone—Constipation—Lovastatin—coronary artery disease	0.000351	0.00249	CcSEcCtD
Molindone—Vision blurred—Furosemide—coronary artery disease	0.000351	0.00249	CcSEcCtD
Molindone—Rash—Gemfibrozil—coronary artery disease	0.000347	0.00246	CcSEcCtD
Molindone—Dermatitis—Gemfibrozil—coronary artery disease	0.000347	0.00246	CcSEcCtD
Molindone—Muscle spasms—Losartan—coronary artery disease	0.000346	0.00245	CcSEcCtD
Molindone—Constipation—Ezetimibe—coronary artery disease	0.000344	0.00244	CcSEcCtD
Molindone—Tachycardia—Niacin—coronary artery disease	0.000344	0.00244	CcSEcCtD
Molindone—Dry mouth—Trandolapril—coronary artery disease	0.000344	0.00244	CcSEcCtD
Molindone—Leukopenia—Perindopril—coronary artery disease	0.000343	0.00243	CcSEcCtD
Molindone—Dry mouth—Enalapril—coronary artery disease	0.000343	0.00243	CcSEcCtD
Molindone—Dyspnoea—Simvastatin—coronary artery disease	0.000342	0.00243	CcSEcCtD
Molindone—Agitation—Furosemide—coronary artery disease	0.000342	0.00243	CcSEcCtD
Molindone—Rash—Ticagrelor—coronary artery disease	0.000339	0.00241	CcSEcCtD
Molindone—Dermatitis—Ticagrelor—coronary artery disease	0.000339	0.00241	CcSEcCtD
Molindone—Hypotension—Valsartan—coronary artery disease	0.000339	0.0024	CcSEcCtD
Molindone—Vision blurred—Losartan—coronary artery disease	0.000339	0.0024	CcSEcCtD
Molindone—Dry mouth—Telmisartan—coronary artery disease	0.000338	0.0024	CcSEcCtD
Molindone—Hypotension—Olmesartan—coronary artery disease	0.000337	0.00239	CcSEcCtD
Molindone—Constipation—Eplerenone—coronary artery disease	0.000337	0.00239	CcSEcCtD
Molindone—Tremor—Losartan—coronary artery disease	0.000337	0.00239	CcSEcCtD
Molindone—Leukopenia—Furosemide—coronary artery disease	0.000333	0.00237	CcSEcCtD
Molindone—Agitation—Losartan—coronary artery disease	0.00033	0.00234	CcSEcCtD
Molindone—Hypotension—Niacin—coronary artery disease	0.00033	0.00234	CcSEcCtD
Molindone—Tachycardia—Trandolapril—coronary artery disease	0.000329	0.00233	CcSEcCtD
Molindone—Dry mouth—Captopril—coronary artery disease	0.000329	0.00233	CcSEcCtD
Molindone—Constipation—Simvastatin—coronary artery disease	0.000328	0.00233	CcSEcCtD
Molindone—Tachycardia—Enalapril—coronary artery disease	0.000328	0.00232	CcSEcCtD
Molindone—Nausea—Gemfibrozil—coronary artery disease	0.000327	0.00232	CcSEcCtD
Molindone—Dyspnoea—Valsartan—coronary artery disease	0.000323	0.00229	CcSEcCtD
Molindone—Tachycardia—Telmisartan—coronary artery disease	0.000323	0.00229	CcSEcCtD
Molindone—Somnolence—Valsartan—coronary artery disease	0.000322	0.00229	CcSEcCtD
Molindone—Leukopenia—Losartan—coronary artery disease	0.000322	0.00228	CcSEcCtD
Molindone—Nausea—Ticagrelor—coronary artery disease	0.00032	0.00227	CcSEcCtD
Molindone—Dry mouth—Perindopril—coronary artery disease	0.000319	0.00226	CcSEcCtD
Molindone—Hypotension—Trandolapril—coronary artery disease	0.000315	0.00223	CcSEcCtD
Molindone—Dyspnoea—Niacin—coronary artery disease	0.000314	0.00223	CcSEcCtD
Molindone—Tachycardia—Captopril—coronary artery disease	0.000314	0.00223	CcSEcCtD
Molindone—Hypotension—Enalapril—coronary artery disease	0.000314	0.00223	CcSEcCtD
Molindone—Somnolence—Niacin—coronary artery disease	0.000313	0.00222	CcSEcCtD
Molindone—Dry mouth—Furosemide—coronary artery disease	0.00031	0.0022	CcSEcCtD
Molindone—Constipation—Valsartan—coronary artery disease	0.00031	0.0022	CcSEcCtD
Molindone—Dyspnoea—Pravastatin—coronary artery disease	0.00031	0.0022	CcSEcCtD
Molindone—Hypotension—Telmisartan—coronary artery disease	0.00031	0.0022	CcSEcCtD
Molindone—Constipation—Olmesartan—coronary artery disease	0.000309	0.00219	CcSEcCtD
Molindone—Rash—Rosuvastatin—coronary artery disease	0.000305	0.00217	CcSEcCtD
Molindone—Tachycardia—Perindopril—coronary artery disease	0.000305	0.00217	CcSEcCtD
Molindone—Dermatitis—Rosuvastatin—coronary artery disease	0.000305	0.00216	CcSEcCtD
Molindone—Hypotension—Captopril—coronary artery disease	0.000301	0.00213	CcSEcCtD
Molindone—Dyspnoea—Trandolapril—coronary artery disease	0.000301	0.00213	CcSEcCtD
Molindone—Somnolence—Trandolapril—coronary artery disease	0.0003	0.00213	CcSEcCtD
Molindone—Dyspnoea—Enalapril—coronary artery disease	0.000299	0.00212	CcSEcCtD
Molindone—Dry mouth—Losartan—coronary artery disease	0.000299	0.00212	CcSEcCtD
Molindone—Somnolence—Enalapril—coronary artery disease	0.000299	0.00212	CcSEcCtD
Molindone—Constipation—Pravastatin—coronary artery disease	0.000297	0.00211	CcSEcCtD
Molindone—Rash—Acetylsalicylic acid—coronary artery disease	0.000297	0.00211	CcSEcCtD
Molindone—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.000296	0.0021	CcSEcCtD
Molindone—Muscle spasms—Ramipril—coronary artery disease	0.000296	0.0021	CcSEcCtD
Molindone—Dyspnoea—Telmisartan—coronary artery disease	0.000295	0.00209	CcSEcCtD
Molindone—Somnolence—Telmisartan—coronary artery disease	0.000294	0.00209	CcSEcCtD
Molindone—Hypotension—Perindopril—coronary artery disease	0.000292	0.00207	CcSEcCtD
Molindone—Tremor—Ramipril—coronary artery disease	0.000289	0.00205	CcSEcCtD
Molindone—Constipation—Trandolapril—coronary artery disease	0.000288	0.00205	CcSEcCtD
Molindone—Nausea—Rosuvastatin—coronary artery disease	0.000288	0.00204	CcSEcCtD
Molindone—Constipation—Enalapril—coronary artery disease	0.000287	0.00204	CcSEcCtD
Molindone—Dyspnoea—Captopril—coronary artery disease	0.000287	0.00204	CcSEcCtD
Molindone—Somnolence—Captopril—coronary artery disease	0.000286	0.00203	CcSEcCtD
Molindone—Tachycardia—Losartan—coronary artery disease	0.000286	0.00203	CcSEcCtD
Molindone—Hypotension—Furosemide—coronary artery disease	0.000284	0.00202	CcSEcCtD
Molindone—Vision blurred—Timolol—coronary artery disease	0.000284	0.00201	CcSEcCtD
Molindone—Constipation—Telmisartan—coronary artery disease	0.000283	0.00201	CcSEcCtD
Molindone—Agitation—Ramipril—coronary artery disease	0.000283	0.00201	CcSEcCtD
Molindone—Nausea—Acetylsalicylic acid—coronary artery disease	0.00028	0.00198	CcSEcCtD
Molindone—Dyspnoea—Perindopril—coronary artery disease	0.000279	0.00198	CcSEcCtD
Molindone—Somnolence—Perindopril—coronary artery disease	0.000278	0.00197	CcSEcCtD
Molindone—Leukopenia—Ramipril—coronary artery disease	0.000276	0.00196	CcSEcCtD
Molindone—Constipation—Captopril—coronary artery disease	0.000275	0.00195	CcSEcCtD
Molindone—Hypotension—Losartan—coronary artery disease	0.000274	0.00194	CcSEcCtD
Molindone—Somnolence—Furosemide—coronary artery disease	0.00027	0.00192	CcSEcCtD
Molindone—Muscle spasms—Lisinopril—coronary artery disease	0.000269	0.00191	CcSEcCtD
Molindone—Constipation—Perindopril—coronary artery disease	0.000267	0.0019	CcSEcCtD
Molindone—Rash—Fenofibrate—coronary artery disease	0.000265	0.00188	CcSEcCtD
Molindone—Dermatitis—Fenofibrate—coronary artery disease	0.000265	0.00188	CcSEcCtD
Molindone—Vision blurred—Lisinopril—coronary artery disease	0.000263	0.00187	CcSEcCtD
Molindone—Tremor—Lisinopril—coronary artery disease	0.000262	0.00186	CcSEcCtD
Molindone—Dyspnoea—Losartan—coronary artery disease	0.000262	0.00186	CcSEcCtD
Molindone—Somnolence—Losartan—coronary artery disease	0.000261	0.00185	CcSEcCtD
Molindone—Rash—Clopidogrel—coronary artery disease	0.000261	0.00185	CcSEcCtD
Molindone—Dermatitis—Clopidogrel—coronary artery disease	0.00026	0.00185	CcSEcCtD
Molindone—Constipation—Furosemide—coronary artery disease	0.00026	0.00184	CcSEcCtD
Molindone—Rash—Lovastatin—coronary artery disease	0.000259	0.00184	CcSEcCtD
Molindone—Dermatitis—Lovastatin—coronary artery disease	0.000259	0.00183	CcSEcCtD
Molindone—Dry mouth—Ramipril—coronary artery disease	0.000257	0.00182	CcSEcCtD
Molindone—Rash—Ezetimibe—coronary artery disease	0.000254	0.0018	CcSEcCtD
Molindone—Dermatitis—Ezetimibe—coronary artery disease	0.000254	0.0018	CcSEcCtD
Molindone—Dry mouth—Timolol—coronary artery disease	0.000251	0.00178	CcSEcCtD
Molindone—Constipation—Losartan—coronary artery disease	0.000251	0.00178	CcSEcCtD
Molindone—Leukopenia—Lisinopril—coronary artery disease	0.00025	0.00177	CcSEcCtD
Molindone—Nausea—Fenofibrate—coronary artery disease	0.00025	0.00177	CcSEcCtD
Molindone—Rash—Eplerenone—coronary artery disease	0.000249	0.00176	CcSEcCtD
Molindone—Dermatitis—Eplerenone—coronary artery disease	0.000248	0.00176	CcSEcCtD
Molindone—Nausea—Clopidogrel—coronary artery disease	0.000246	0.00174	CcSEcCtD
Molindone—Tachycardia—Ramipril—coronary artery disease	0.000245	0.00174	CcSEcCtD
Molindone—Nausea—Lovastatin—coronary artery disease	0.000244	0.00173	CcSEcCtD
Molindone—Rash—Simvastatin—coronary artery disease	0.000242	0.00172	CcSEcCtD
Molindone—Dermatitis—Simvastatin—coronary artery disease	0.000242	0.00172	CcSEcCtD
Molindone—Nausea—Ezetimibe—coronary artery disease	0.000239	0.0017	CcSEcCtD
Molindone—Hypotension—Ramipril—coronary artery disease	0.000235	0.00167	CcSEcCtD
Molindone—Nausea—Eplerenone—coronary artery disease	0.000234	0.00166	CcSEcCtD
Molindone—Dry mouth—Lisinopril—coronary artery disease	0.000233	0.00165	CcSEcCtD
Molindone—Hypotension—Timolol—coronary artery disease	0.00023	0.00163	CcSEcCtD
Molindone—Rash—Valsartan—coronary artery disease	0.000229	0.00162	CcSEcCtD
Molindone—Dermatitis—Valsartan—coronary artery disease	0.000228	0.00162	CcSEcCtD
Molindone—Nausea—Simvastatin—coronary artery disease	0.000228	0.00162	CcSEcCtD
Molindone—Rash—Olmesartan—coronary artery disease	0.000228	0.00161	CcSEcCtD
Molindone—Dermatitis—Olmesartan—coronary artery disease	0.000227	0.00161	CcSEcCtD
Molindone—Dyspnoea—Ramipril—coronary artery disease	0.000224	0.00159	CcSEcCtD
Molindone—Somnolence—Ramipril—coronary artery disease	0.000224	0.00159	CcSEcCtD
Molindone—Tachycardia—Lisinopril—coronary artery disease	0.000223	0.00158	CcSEcCtD
Molindone—Rash—Niacin—coronary artery disease	0.000222	0.00158	CcSEcCtD
Molindone—Dermatitis—Niacin—coronary artery disease	0.000222	0.00158	CcSEcCtD
Molindone—Dyspnoea—Timolol—coronary artery disease	0.000219	0.00155	CcSEcCtD
Molindone—Rash—Pravastatin—coronary artery disease	0.000219	0.00155	CcSEcCtD
Molindone—Dermatitis—Pravastatin—coronary artery disease	0.000219	0.00155	CcSEcCtD
Molindone—Somnolence—Timolol—coronary artery disease	0.000219	0.00155	CcSEcCtD
Molindone—Nausea—Valsartan—coronary artery disease	0.000215	0.00153	CcSEcCtD
Molindone—Constipation—Ramipril—coronary artery disease	0.000215	0.00153	CcSEcCtD
Molindone—Nausea—Olmesartan—coronary artery disease	0.000214	0.00152	CcSEcCtD
Molindone—Hypotension—Lisinopril—coronary artery disease	0.000213	0.00151	CcSEcCtD
Molindone—Rash—Trandolapril—coronary artery disease	0.000213	0.00151	CcSEcCtD
Molindone—Dermatitis—Trandolapril—coronary artery disease	0.000212	0.00151	CcSEcCtD
Molindone—Rash—Enalapril—coronary artery disease	0.000212	0.0015	CcSEcCtD
Molindone—Dermatitis—Enalapril—coronary artery disease	0.000212	0.0015	CcSEcCtD
Molindone—Nausea—Niacin—coronary artery disease	0.000209	0.00149	CcSEcCtD
Molindone—Rash—Telmisartan—coronary artery disease	0.000209	0.00148	CcSEcCtD
Molindone—Dermatitis—Telmisartan—coronary artery disease	0.000209	0.00148	CcSEcCtD
Molindone—Nausea—Pravastatin—coronary artery disease	0.000206	0.00146	CcSEcCtD
Molindone—Dyspnoea—Lisinopril—coronary artery disease	0.000203	0.00144	CcSEcCtD
Molindone—Rash—Captopril—coronary artery disease	0.000203	0.00144	CcSEcCtD
Molindone—Dermatitis—Captopril—coronary artery disease	0.000203	0.00144	CcSEcCtD
Molindone—Somnolence—Lisinopril—coronary artery disease	0.000203	0.00144	CcSEcCtD
Molindone—Nausea—Trandolapril—coronary artery disease	0.0002	0.00142	CcSEcCtD
Molindone—Nausea—Enalapril—coronary artery disease	0.000199	0.00141	CcSEcCtD
Molindone—Rash—Perindopril—coronary artery disease	0.000197	0.0014	CcSEcCtD
Molindone—Dermatitis—Perindopril—coronary artery disease	0.000197	0.0014	CcSEcCtD
Molindone—Nausea—Telmisartan—coronary artery disease	0.000197	0.0014	CcSEcCtD
Molindone—Constipation—Lisinopril—coronary artery disease	0.000195	0.00138	CcSEcCtD
Molindone—Rash—Furosemide—coronary artery disease	0.000192	0.00136	CcSEcCtD
Molindone—Dermatitis—Furosemide—coronary artery disease	0.000192	0.00136	CcSEcCtD
Molindone—Nausea—Captopril—coronary artery disease	0.000191	0.00136	CcSEcCtD
Molindone—Nausea—Perindopril—coronary artery disease	0.000186	0.00132	CcSEcCtD
Molindone—Rash—Losartan—coronary artery disease	0.000185	0.00131	CcSEcCtD
Molindone—Dermatitis—Losartan—coronary artery disease	0.000185	0.00131	CcSEcCtD
Molindone—Nausea—Furosemide—coronary artery disease	0.000181	0.00128	CcSEcCtD
Molindone—Nausea—Losartan—coronary artery disease	0.000174	0.00124	CcSEcCtD
Molindone—Rash—Ramipril—coronary artery disease	0.000159	0.00112	CcSEcCtD
Molindone—Dermatitis—Ramipril—coronary artery disease	0.000158	0.00112	CcSEcCtD
Molindone—Rash—Timolol—coronary artery disease	0.000155	0.0011	CcSEcCtD
Molindone—Dermatitis—Timolol—coronary artery disease	0.000155	0.0011	CcSEcCtD
Molindone—Nausea—Ramipril—coronary artery disease	0.000149	0.00106	CcSEcCtD
Molindone—Nausea—Timolol—coronary artery disease	0.000146	0.00104	CcSEcCtD
Molindone—Rash—Lisinopril—coronary artery disease	0.000144	0.00102	CcSEcCtD
Molindone—Dermatitis—Lisinopril—coronary artery disease	0.000144	0.00102	CcSEcCtD
Molindone—Nausea—Lisinopril—coronary artery disease	0.000135	0.000961	CcSEcCtD
Molindone—HTR2A—Signaling Pathways—ITGB3—coronary artery disease	6.96e-06	5.13e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—ITGB3—coronary artery disease	6.92e-06	5.1e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—APOA1—coronary artery disease	6.91e-06	5.09e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—CXCL8—coronary artery disease	6.91e-06	5.09e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PPP2CA—coronary artery disease	6.87e-06	5.06e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—JAK2—coronary artery disease	6.87e-06	5.06e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—APOB—coronary artery disease	6.87e-06	5.06e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—KDR—coronary artery disease	6.85e-06	5.05e-05	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—PIK3CA—coronary artery disease	6.84e-06	5.03e-05	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—CXCL8—coronary artery disease	6.81e-06	5.01e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MAPK14—coronary artery disease	6.81e-06	5.01e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—CXCL8—coronary artery disease	6.8e-06	5.01e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—JAK2—coronary artery disease	6.78e-06	4.99e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PPP2CA—coronary artery disease	6.76e-06	4.98e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—CXCL8—coronary artery disease	6.76e-06	4.98e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—EDN1—coronary artery disease	6.76e-06	4.98e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PRKCD—coronary artery disease	6.75e-06	4.97e-05	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—PIK3CA—coronary artery disease	6.74e-06	4.96e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PPP2CA—coronary artery disease	6.73e-06	4.95e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—AGT—coronary artery disease	6.71e-06	4.94e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CCL5—coronary artery disease	6.71e-06	4.94e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—ESR1—coronary artery disease	6.68e-06	4.92e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PRKCD—coronary artery disease	6.64e-06	4.89e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—FGF1—coronary artery disease	6.61e-06	4.87e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CSF2—coronary artery disease	6.61e-06	4.87e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PRKCD—coronary artery disease	6.61e-06	4.86e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—HTR2A—coronary artery disease	6.61e-06	4.86e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—C3—coronary artery disease	6.6e-06	4.86e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—F2—coronary artery disease	6.6e-06	4.86e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—FN1—coronary artery disease	6.6e-06	4.86e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—APOE—coronary artery disease	6.57e-06	4.84e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IL6ST—coronary artery disease	6.57e-06	4.84e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—LPL—coronary artery disease	6.56e-06	4.83e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—NFKBIA—coronary artery disease	6.52e-06	4.8e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MEF2C—coronary artery disease	6.5e-06	4.79e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—RPS6KB1—coronary artery disease	6.5e-06	4.79e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—APOA1—coronary artery disease	6.5e-06	4.79e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—C3—coronary artery disease	6.49e-06	4.78e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—HTR2A—coronary artery disease	6.46e-06	4.76e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—C3—coronary artery disease	6.46e-06	4.75e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—ITGB3—coronary artery disease	6.33e-06	4.66e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—KIT—coronary artery disease	6.31e-06	4.65e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—HIF1A—coronary artery disease	6.29e-06	4.63e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—CXCL8—coronary artery disease	6.27e-06	4.62e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—AGT—coronary artery disease	6.27e-06	4.62e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—HIF1A—coronary artery disease	6.19e-06	4.56e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—CXCL8—coronary artery disease	6.18e-06	4.55e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—AGT—coronary artery disease	6.17e-06	4.54e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—HIF1A—coronary artery disease	6.16e-06	4.53e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PPP2CA—coronary artery disease	6.15e-06	4.53e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—LEP—coronary artery disease	6.14e-06	4.52e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—APOE—coronary artery disease	6.14e-06	4.52e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—AGT—coronary artery disease	6.13e-06	4.52e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—APOA1—coronary artery disease	6.07e-06	4.47e-05	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—AKT1—coronary artery disease	6.06e-06	4.46e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—GSK3B—coronary artery disease	6.06e-06	4.46e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PRKCD—coronary artery disease	6.04e-06	4.45e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—APOE—coronary artery disease	6.04e-06	4.45e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—LEP—coronary artery disease	6.04e-06	4.45e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—KDR—coronary artery disease	6.02e-06	4.43e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—LEP—coronary artery disease	6.01e-06	4.43e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—APOE—coronary artery disease	6.01e-06	4.43e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—POMC—coronary artery disease	6.01e-06	4.42e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CREB1—coronary artery disease	6.01e-06	4.42e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—CASP3—coronary artery disease	6e-06	4.42e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MAPK14—coronary artery disease	5.98e-06	4.4e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—APOA1—coronary artery disease	5.97e-06	4.4e-05	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—IL6—coronary artery disease	5.96e-06	4.39e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—APOA1—coronary artery disease	5.94e-06	4.38e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—KDR—coronary artery disease	5.92e-06	4.36e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—HTR2A—coronary artery disease	5.91e-06	4.35e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—C3—coronary artery disease	5.9e-06	4.35e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—KDR—coronary artery disease	5.89e-06	4.34e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MAPK14—coronary artery disease	5.88e-06	4.33e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CCL2—coronary artery disease	5.88e-06	4.33e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—ESR1—coronary artery disease	5.86e-06	4.32e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IL6R—coronary artery disease	5.86e-06	4.32e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MAPK14—coronary artery disease	5.85e-06	4.31e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—CCND1—coronary artery disease	5.84e-06	4.3e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—FN1—coronary artery disease	5.79e-06	4.26e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—F2—coronary artery disease	5.79e-06	4.26e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IGF1—coronary artery disease	5.78e-06	4.26e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—ESR1—coronary artery disease	5.77e-06	4.25e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IL6ST—coronary artery disease	5.77e-06	4.25e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—MAPK1—coronary artery disease	5.75e-06	4.24e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—ESR1—coronary artery disease	5.74e-06	4.23e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PPARG—coronary artery disease	5.73e-06	4.22e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—NFKBIA—coronary artery disease	5.72e-06	4.21e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—F2—coronary artery disease	5.7e-06	4.2e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—FN1—coronary artery disease	5.7e-06	4.2e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IL6ST—coronary artery disease	5.68e-06	4.18e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—MMP9—coronary artery disease	5.67e-06	4.18e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—F2—coronary artery disease	5.67e-06	4.17e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—FN1—coronary artery disease	5.67e-06	4.17e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—POMC—coronary artery disease	5.65e-06	4.16e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	5.64e-06	4.16e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—HIF1A—coronary artery disease	5.63e-06	4.15e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—NFKBIA—coronary artery disease	5.63e-06	4.15e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—AGT—coronary artery disease	5.61e-06	4.13e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	5.6e-06	4.12e-05	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—AKT1—coronary artery disease	5.58e-06	4.11e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—KIT—coronary artery disease	5.54e-06	4.08e-05	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—AKT1—coronary artery disease	5.5e-06	4.05e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—LEP—coronary artery disease	5.5e-06	4.05e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—APOE—coronary artery disease	5.5e-06	4.05e-05	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—PIK3CA—coronary artery disease	5.5e-06	4.05e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—SERPINE1—coronary artery disease	5.49e-06	4.04e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—KIT—coronary artery disease	5.45e-06	4.02e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—APOA1—coronary artery disease	5.43e-06	4e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—KIT—coronary artery disease	5.42e-06	3.99e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—KDR—coronary artery disease	5.39e-06	3.97e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MAPK14—coronary artery disease	5.35e-06	3.94e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—GSK3B—coronary artery disease	5.32e-06	3.92e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—FGF2—coronary artery disease	5.31e-06	3.91e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—POMC—coronary artery disease	5.28e-06	3.88e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CREB1—coronary artery disease	5.28e-06	3.88e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—ESR1—coronary artery disease	5.25e-06	3.86e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—NOS3—coronary artery disease	5.24e-06	3.86e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—GSK3B—coronary artery disease	5.23e-06	3.85e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	5.2e-06	3.83e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—POMC—coronary artery disease	5.19e-06	3.82e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CREB1—coronary artery disease	5.19e-06	3.82e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—F2—coronary artery disease	5.18e-06	3.82e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—FN1—coronary artery disease	5.18e-06	3.82e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IL6ST—coronary artery disease	5.16e-06	3.8e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—POMC—coronary artery disease	5.16e-06	3.8e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CREB1—coronary artery disease	5.16e-06	3.8e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CCL2—coronary artery disease	5.16e-06	3.8e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—ALB—coronary artery disease	5.15e-06	3.79e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IL6R—coronary artery disease	5.15e-06	3.79e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—NFKBIA—coronary artery disease	5.12e-06	3.77e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—VEGFA—coronary artery disease	5.09e-06	3.75e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—JAK2—coronary artery disease	5.09e-06	3.75e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CCL2—coronary artery disease	5.08e-06	3.74e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IGF1—coronary artery disease	5.07e-06	3.74e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IL6R—coronary artery disease	5.06e-06	3.73e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CCL2—coronary artery disease	5.05e-06	3.72e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—MAPK1—coronary artery disease	5.05e-06	3.72e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IL6R—coronary artery disease	5.04e-06	3.71e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IGF1—coronary artery disease	4.99e-06	3.68e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—PIK3CA—coronary artery disease	4.99e-06	3.68e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—MAPK1—coronary artery disease	4.97e-06	3.66e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IGF1—coronary artery disease	4.97e-06	3.66e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—KIT—coronary artery disease	4.96e-06	3.65e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	4.94e-06	3.64e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—NOS3—coronary artery disease	4.93e-06	3.63e-05	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—PIK3CA—coronary artery disease	4.83e-06	3.55e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—SERPINE1—coronary artery disease	4.82e-06	3.55e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—GSK3B—coronary artery disease	4.76e-06	3.51e-05	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—PIK3CA—coronary artery disease	4.75e-06	3.5e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—SERPINE1—coronary artery disease	4.74e-06	3.49e-05	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	4.72e-06	3.48e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—POMC—coronary artery disease	4.72e-06	3.48e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CREB1—coronary artery disease	4.72e-06	3.48e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	4.72e-06	3.47e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—TGFB1—coronary artery disease	4.68e-06	3.44e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—FGF2—coronary artery disease	4.66e-06	3.44e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CXCL8—coronary artery disease	4.65e-06	3.42e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	4.62e-06	3.4e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	4.61e-06	3.39e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—NOS3—coronary artery disease	4.6e-06	3.39e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—FGF2—coronary artery disease	4.59e-06	3.38e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—MAPK1—coronary artery disease	4.59e-06	3.38e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—FGF2—coronary artery disease	4.57e-06	3.36e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	4.54e-06	3.35e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—NOS3—coronary artery disease	4.53e-06	3.33e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	4.52e-06	3.33e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PTGS2—coronary artery disease	4.5e-06	3.32e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—NOS3—coronary artery disease	4.5e-06	3.32e-05	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	4.49e-06	3.31e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—JAK2—coronary artery disease	4.47e-06	3.29e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CASP3—coronary artery disease	4.45e-06	3.28e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—IL6—coronary artery disease	4.42e-06	3.25e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—JAK2—coronary artery disease	4.4e-06	3.24e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	4.38e-06	3.23e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—JAK2—coronary artery disease	4.38e-06	3.22e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CCND1—coronary artery disease	4.33e-06	3.19e-05	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	4.32e-06	3.18e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	4.31e-06	3.18e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	4.31e-06	3.18e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	4.29e-06	3.16e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MMP9—coronary artery disease	4.2e-06	3.1e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	4.18e-06	3.08e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	4.12e-06	3.03e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CXCL8—coronary artery disease	4.08e-06	3.01e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	4.08e-06	3e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	4.02e-06	2.96e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	4e-06	2.95e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	3.99e-06	2.94e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—PIK3CA—coronary artery disease	3.98e-06	2.93e-05	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	3.94e-06	2.9e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	3.92e-06	2.89e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CASP3—coronary artery disease	3.91e-06	2.88e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—IL6—coronary artery disease	3.88e-06	2.86e-05	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	3.88e-06	2.86e-05	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	3.86e-06	2.84e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CASP3—coronary artery disease	3.84e-06	2.83e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CASP3—coronary artery disease	3.82e-06	2.82e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—IL6—coronary artery disease	3.82e-06	2.81e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CCND1—coronary artery disease	3.8e-06	2.8e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—IL6—coronary artery disease	3.8e-06	2.8e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	3.77e-06	2.78e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CCND1—coronary artery disease	3.74e-06	2.75e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CCND1—coronary artery disease	3.72e-06	2.74e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MMP9—coronary artery disease	3.69e-06	2.72e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	3.65e-06	2.69e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MMP9—coronary artery disease	3.63e-06	2.67e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MMP9—coronary artery disease	3.61e-06	2.66e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—AKT1—coronary artery disease	3.58e-06	2.64e-05	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	3.53e-06	2.6e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—IL6—coronary artery disease	3.52e-06	2.59e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	3.52e-06	2.59e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	3.5e-06	2.58e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	3.5e-06	2.57e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	3.47e-06	2.56e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	3.46e-06	2.55e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	3.4e-06	2.51e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	3.4e-06	2.5e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—VEGFA—coronary artery disease	3.31e-06	2.44e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	3.3e-06	2.43e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	3.26e-06	2.4e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—AKT1—coronary artery disease	3.25e-06	2.39e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	3.24e-06	2.39e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	3.2e-06	2.36e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—TGFB1—coronary artery disease	3.04e-06	2.24e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	2.99e-06	2.2e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MAPK1—coronary artery disease	2.98e-06	2.2e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	2.98e-06	2.19e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	2.97e-06	2.18e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	2.95e-06	2.17e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	2.94e-06	2.16e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	2.92e-06	2.15e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PIK3CA—coronary artery disease	2.77e-06	2.04e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	2.72e-06	2.01e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	2.67e-06	1.97e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IL6—coronary artery disease	2.61e-06	1.92e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	2.59e-06	1.91e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	2.55e-06	1.88e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	2.53e-06	1.87e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—AKT1—coronary artery disease	2.41e-06	1.77e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	2.32e-06	1.71e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IL6—coronary artery disease	2.29e-06	1.69e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—AKT1—coronary artery disease	2.26e-06	1.67e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IL6—coronary artery disease	2.26e-06	1.66e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IL6—coronary artery disease	2.24e-06	1.65e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—AKT1—coronary artery disease	2.11e-06	1.56e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—AKT1—coronary artery disease	2.08e-06	1.53e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—AKT1—coronary artery disease	2.07e-06	1.52e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IL6—coronary artery disease	2.05e-06	1.51e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	1.89e-06	1.39e-05	CbGpPWpGaD
